https://pubmed.ncbi.nlm.nih.gov/24315100/
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade
The treatment of advanced prostate cancer has been transformed by novel antiandrogen therapies such as enzalutamide. Here, we identify induction of...
glucocorticoid receptorresistanceantiandrogensblockade